propofol
Propofol (Diprivan) is an intravenous anesthetic and sedative given in hospitals to induce and maintain general anesthesia, to sedate adults during monitored care or with regional anesthesia, and to sedate intubated adults in the intensive care unit. It works within minutes and wears off quickly.
This page is based on FDA prescribing information for propofol injectable emulsion, cross-checked with the National Cancer Institute dictionary; the mechanism is explained in plain language, and analogies are used only where they stay accurate.
How it works
Explains what the medicine does in the body, not dosing, side effects, or safety.
An analogy
The brain has a volume dial for wakefulness. Propofol turns the dial down hard and fast by boosting the brain's own calming signal, GABA. Consciousness fades within a minute or two, and because the drug is cleared quickly, the dial comes back up soon after the infusion stops, which is why it suits both short procedures and adjustable intensive care sedation.
In simple terms
Propofol is a hypnotic drug given through a vein as a milky emulsion. It enhances inhibitory neurotransmission mediated by gamma-aminobutyric acid (GABA), the brain's main calming signal, producing sedation and hypnosis. It acts quickly and has a short duration of action of roughly two to ten minutes, with minimal respiratory depression at typical use. Anesthesia teams use it to put patients to sleep for surgery, keep them asleep, or provide controlled sedation in monitored settings and intensive care.
In depth
Propofol is a hypnotic alkylphenol derivative formulated as an intravenous emulsion for induction of sedation and hypnosis during anesthesia. It facilitates inhibitory neurotransmission mediated by gamma-aminobutyric acid (GABA). The agent is associated with minimal respiratory depression at usual clinical exposure and has a short half-life with a duration of action of two to ten minutes, allowing rapid induction and rapid recovery. It is not recommended for induction below age three years, for maintenance below two months of age, or for pediatric ICU sedation, where safety has not been established.
See it in motion
A schematic animation of the mechanism — simplified for clarity, not drawn to scale.
How GABA-anesthetic agents work
- GABA-A receptors on neurons open a chloride channel when GABA binds, quieting the cell.
- The anesthetic binds a separate site on the same receptor and makes it more responsive to GABA.
- Chloride flows in more readily, so neurons fire less often and circuits slow down.
- Enhancing that calming signal quiets nerve activity, producing sedation, hypnosis and loss of consciousness during anesthesia.
Target: Gamma-aminobutyric acid (GABA) inhibitory neurotransmission
The brain's main calming signal system; enhancing it quiets nerve activity, producing sedation, hypnosis, and loss of consciousness during anesthesia.
Approved uses
Approved uses differ by country and change over time. Always follow your local prescribing information.
Approved uses in United States
FDA- For induction of general anesthesia in patients 3 years of age and older
- For maintenance of general anesthesia in patients 2 months of age and older
- For initiation and maintenance of monitored anesthesia care (MAC) sedation in adult patients
- For sedation of adult patients in combination with regional anesthesia
- For intensive care unit (ICU) sedation of intubated, mechanically ventilated adult patients
Official sources
The statements on this page trace back to these records.
- U.S. Food and Drug Administration: propofol prescribing information
U.S. Food and Drug Administration
- National Cancer Institute: propofol
National Cancer Institute
This page explains how the medicine works — it isn’t the patient leaflet. For anything that applies to you, read the leaflet that came with your medicine or ask your pharmacist.
MedUnfold provides educational content and is not medical advice. Always follow your local prescribing information and healthcare professional.